ACE2 and COVID-19: To confirm that ACE2-expressing pericytes induce COVID-19-related thyroid disorders, it is necessary to simultaneously identify perivascular infection with SARS-CoV-2 and inflammation in the perivascular area of patients with COVID-19 presenting with thyroid dysfunction.